Worldwide: Food, Drugs, Healthcare, Life Sciences

Santé Canada a publié ses rapports trimestriels pour les deuxième et troisième trimestres de 2025-2026, présentant des données détaillées sur les délais de traitement des demandes d'autorisation de mise en marché d'instruments médicaux.

A landmark Ontario court decision found a plastic surgeon liable for installing surveillance cameras throughout his clinic, including in areas where patients disrobed and received treatment.

In J.C. et al. v. Jugenburg et al., 2026 ONSC 3061, the court found that a plastic surgeon breached his duties to patients and intruded on their privacy by installing surveillance cameras throughout his clinic.

The 2026 annual Bloom Burton & Co. Healthcare Investor Conference—Canada's premier international forum for healthcare companies and investors—was held in late April in Toronto.

On March 26, 2026, Canada's new transfer pricing rules received royal assent and will have a significant impact on multi-national enterprises (MNEs) in life sciences industries.

Health Canada released a notice to industry on April 24, 2026, outlining that manufacturers must use the Regulatory Enrolment Process (REP) and Common Electronic Submission Gateway (CESG) for medical device transactions as of April 1, 2026. As we previously reported, manufacturers of medical devices could voluntarily use the REP and CESG for medical device regulatory transactions as of July 2024.

Health Canada has issued a new Guidance Document pertaining to biosimilar drug submissions. The new Guidance significantly reduces the supporting clinical safety...

On April 30, 2026, Canada’s Drug Agency (CDA) published updated Procedures for Reimbursement Reviews, following completion of a public consultation earlier this year. The updated procedures will be effective for August 2026 submissions and expert committee meetings in January 2027.

As previously reported, Health Canada has proposed a Ministerial Reliance Order that would allow Health Canada to rely on decisions of foreign regulatory authorities (FRAs). Health Canada has proposed that the Reliance Order will come into force in summer 2026, at which point Health Canada will consult on an applicable guidance document.